Change in Directors' interests in the shares of BTG plc ("BTG" or the "Company")
This notification is made in accordance with the Company's obligations under the Market Abuse Regulation.
The following transaction has taken place in relation to the executive directors under the Company's share plans.
Deferred Share Bonus Plan
The Company has awarded bonuses to its executive directors with respect to the financial year 2018/19. The bonus is paid as a mix of cash and shares, with the first 75% of salary of any bonus being paid in cash, with any bonus in excess of 75% of salary being awarded in shares under the Company's Deferred Share Bonus Plan. For 2019 this comprises 61,513 shares for Louise Makin and 33,614 shares for Duncan Kennedy. Under the terms of the Plan these shares will normally be released in full to the directors only after a further three years' service or on completion of the acquisition of the Company by Boston Scientific Corporation prior to the normal vesting date.
Notification and public disclosure of transactions by persons discharging managerial responsibilities.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||||
|
a)
|
Name
|
Louise Makin |
|||||
|
2
|
Reason for the notification
|
||||||
|
a)
|
Position/status
|
CEO, Director |
|||||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||||
|
a)
|
Name
|
BTG plc |
|||||
|
b)
|
LEI
|
213800DCVRNVRVINH968 |
|||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||
|
1
|
Description of the financial instrument, type of instrument |
Ordinary Shares of 10p |
|||||
|
|
|
||||||
|
Identification code |
GB0001001592 |
||||||
|
|
|
||||||
|
|
Nature of the transaction
|
Grant of awards under the Company's Deferred Share Bonus Plan |
|||||
|
|
Price(s) and volume(s) |
|
|
|
|
||
|
|
|
Price(s) |
Volume(s) |
Total |
|
||
|
|
|
£0 |
61,513 |
£0 |
|
||
|
|
|
|
|
|
|||
|
|
Aggregated information |
|
|||||
|
- Aggregated Volume |
61,513 |
||||||
|
- Price |
£0 |
||||||
|
|
|
||||||
|
|
Date of the transaction
|
22 July 2019 |
|||||
|
|
Place of the transaction
|
Outside a trading venue |
|||||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||||
|
a)
|
Name
|
Duncan Kennedy |
|||||
|
2
|
Reason for the notification
|
||||||
|
a)
|
Position/status
|
CFO, Director |
|||||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||||
|
a)
|
Name
|
BTG plc |
|||||
|
b)
|
LEI
|
213800DCVRNVRVINH968 |
|||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||
|
|
Description of the financial instrument, type of instrument |
Ordinary Shares of 10p |
|||||
|
|
|
||||||
|
Identification code |
GB0001001592 |
||||||
|
|
|
||||||
|
|
Nature of the transaction
|
Grant of awards under the Company's Deferred Share Bonus Plan |
|||||
|
|
Price(s) and volume(s) |
|
|
|
|
||
|
|
|
Price(s) |
Volume(s) |
Total |
|
||
|
|
|
£0 |
33,614 |
£0 |
|
||
|
|
|
|
|
|
|||
|
|
Aggregated information
|
|
|||||
|
- Aggregated Volume
|
33,614 |
||||||
|
- Price
|
£0 |
||||||
|
|
|
||||||
|
|
Date of the transaction
|
22 July 2019 |
|||||
|
|
Place of the transaction
|
Outside a trading venue |
|||||
Enquiries:
Andy Burrows, Vice President, Corporate and Investor Relations
+44 (0)20 7575 1741; Mobile: +44 (0)7990 530605
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
